An overview of epigenetics and chemoprevention
- 5 November 2010
- journal article
- review article
- Published by Wiley in FEBS Letters
- Vol. 585 (13) , 2129-2136
Abstract
It is now appreciated that both genetic alteration, e.g. mutations, and aberrant epigenetic changes, e.g. DNA methylation, cause cancer. Epigenetic dysregulation is potentially reversible which makes it attractive as targets for cancer prevention. Synthetic drugs targeting enzymes, e.g. DNA methyltransferase and histone deacetylase, that regulate epigenetic patterns are active in clinical settings. In addition, dietary factors have been suggested to have potential to reverse aberrant epigenetic patterns. Uncovering the human epigenome can lead us to better understand the dynamics of DNA methylation in disease progression which can further assist in cancer prevention.Keywords
Funding Information
- NCI (CA148818)
This publication has 73 references indexed in Scilit:
- DNMT3B7, a Truncated DNMT3B Isoform Expressed in Human Tumors, Disrupts Embryonic Development and Accelerates LymphomagenesisCancer Research, 2010
- Integrated Profiling Reveals a Global Correlation between Epigenetic and Genetic Alterations in MesotheliomaCancer Research, 2010
- Chromatin Remodeling in Mammary Gland Differentiation and Breast TumorigenesisCold Spring Harbor Perspectives in Biology, 2010
- Estrogen-mediated epigenetic repression of large chromosomal regions through DNA loopingGenome Research, 2010
- Widespread and tissue specific age-related DNA methylation changes in miceGenome Research, 2010
- Global DNA Hypomethylation (LINE-1) in the Normal Colon and Lifestyle Characteristics and Dietary and Genetic FactorsCancer Epidemiology, Biomarkers & Prevention, 2009
- BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancerCarcinogenesis, 2009
- Genomic and Epigenetic Instability in Colorectal Cancer PathogenesisGastroenterology, 2008
- Epigenetic therapy of cancer: past, present and futureNature Reviews Drug Discovery, 2006
- The history of cancer epigeneticsNature Reviews Cancer, 2004